Caricamento...
Synthetic Lethal Vulnerabilities in KRAS-Mutant Cancers
KRAS is the most commonly mutated oncogene in human cancer. Most KRAS-mutant cancers depend on sustained expression and signaling of KRAS, thus making it a high-priority therapeutic target. Unfortunately, development of direct small molecule inhibitors of KRAS function has been challenging. An alter...
Salvato in:
| Pubblicato in: | Cold Spring Harb Perspect Med |
|---|---|
| Autori principali: | , |
| Natura: | Artigo |
| Lingua: | Inglês |
| Pubblicazione: |
Cold Spring Harbor Laboratory Press
2018
|
| Soggetti: | |
| Accesso online: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5990478/ https://ncbi.nlm.nih.gov/pubmed/29101114 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1101/cshperspect.a031518 |
| Tags: |
Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !
|